Browse the full archive, newest first.
Strategic angle: Will the FDA’s regulatory policies, particularly for rare-disease drugs, shift in the wake of Vinay Prasad’s imminent departure?
Strategic angle: Iran's Gulf neighbors have said attacks on energy infrastructure won't "go unanswered," but, so far, they have not hit back at Iran. That stance could change soon.
Strategic angle: The tech giant is one of several Chinese AI firms that have been rushing to catch up to U.S. companies in the AI race.
Executive context: Chart-topping artist Afroman faces legal victory as lawsuit from Ohio police is dismissed.
Strategic angle: An overview of the significant updates in the Nuclear Power Facilities Draft by Dentons.
Strategic angle: A Paris appeals court has dismissed the French government's attempt to suspend the controversial e-commerce platform Shein.
Strategic angle: Military users express concerns over the potential removal of Anthropic's AI tool.
Executive context: The award-winning musician opens up about his struggles with stigma and shame while seeking help.
Strategic angle: A new study reveals how plants adapt to extreme drought conditions in the American Southwest.
Strategic angle: Autism experts plan to convene in Washington Thursday to propose a research agenda at odds with the one endorsed by the Trump Administration.